Hold BRK-B with $492 structural stop and $529 price target; await Q3 earnings catalyst for directional clarity
The three-analyst HOLD consensus reflects genuinely balanced evidence rather than alignment of bearish signals. The aggressive analyst's $365B cash fortress (34% of market cap), $72B FCF, 32.6% operating margins, 0.607 beta, Aaa rating, and $4.21B Q2 buyback signal real fundamental strength, while the conservative analyst correctly identifies the 57.9% investment-mark dependency inflating trailing P/E, the forward P/E of 22.39x as a GAAP premium to S&P 500, and deteriorating momentum (broken 50 SMA, expanding negative MACD histogram, IBD bearish trigger). The 200 SMA at $492 has held for months and the long-term uptrend remains intact alongside the cash fortress and Abel buying signal. Anchor invalidation at $490-$492 with daily close requirement (not intraday wick risk) and volume confirmation >4M shares. The Abel buyback resumption needs Q3 and Q4 validation before earning regime-change weight. Do not add at $496 into deteriorating momentum without constructive reversal evidence; the expected value of adding now versus waiting for $503 is unfavorable given the $1.06T name's $7.66 ATR and 0.607 beta means the cost of waiting is one macro day while the cost of being early into a 200 SMA break is the entire thesis.
| Position | Action |
|---|---|
| Default: maintain current BRK-B exposure | Hold position; do not add at spot despite 6% pullback |
| Confirmed daily close below $492 on volume >4M shares (breaks structural thesis) | Trim 25-40% of position |
| Confirmed close above $501 (50 SMA) with RSI holding above 45 and MACD histogram showing first signs of bottoming | Consider staged add to position |
| Confirmed close above $503 with MACD histogram contracting toward zero | Full staged add with increased conviction |
The pullback is a gift, not a warning — Berkshire's long-term uptrend is intact, management's $35B cash deployment signals undervaluation, and the stock is trading at a compelling 12.49x P/E on record earnings with accelerating buybacks providing a persistent bid.
| Indicator | Value | Signal |
|---|---|---|
| Close | $496.86 | neutral |
| Open | $499.64 | neutral |
| High | $500.44 | neutral |
| Low | $496.48 | neutral |
| Volume | 2,344,741 | bullish |
| 10 EMA | $504.96 | bearish |
| 50 SMA | $500.15 | neutral |
| 200 SMA | $492.02 | bullish |
| RSI(14) | 42.76 | neutral |
| RSI Peak | 74.55 (2026-08-10) | bearish |
| MACD | +0.63 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed close above $503 with MACD histogram contracting toward zero
Then: Full staged add with momentum confirmation
Forward P/E of 22.39x is misleading because Q2 2026 net income was inflated by $14.85B in one-time investment gains.
↩ rebuts: “Bear interpretation of forward P/E as evidence of 44% earnings decline”
EV: +$5.2% to $522 (50 SMA retest), extended target $560+ · concedes: Bear is correct that short-term technicals are bearish (price below 10 EMA and 50 SMA); Forward P/E of 22.39x is higher than TTM P/E of 12.49x; PEG ratio of 10.06 is elevated relative to growth stocks; 29.7% concentration in two AI names (Alphabet) represents meaningful position risk; A structural stop below the 200 SMA ($487) is warranted if support fails; 86% implied odds of no rate cuts creates opportunity cost for waiting
BRK-B faces a structural breakdown risk: the 6% pullback could be the first leg of a 20%+ decline as technical momentum deteriorates, forward earnings normalize downward 44%, Abel's unproven capital allocation creates execution risk, and macro conditions (energy spike, elevated rates, risk-off correlation) create asymmetric downside with target $478 and stop at $540.
EV: -$478 target (below 200 SMA at $492 with buffer) · concedes: Technically true that a 6% pullback doesn't always break a long-term uptrend, but the tape is giving more reasons to suspect this is the first leg of a 20% breakdown; Analysts may be properly normalizing Q2's outsized investment gains, but this makes the bull case worse by showing the stock is more expensive on forward earnings than it has been at almost any point in the last five years; Buffett's buyback history is a strong signal—but Abel's buyback pace is unproven and extrapolating a 60-year philosophy from one quarter is statistically meaningless
→ vs conservative: The $492 stop is too tight at only 0.6 ATR (roughly $8) — described as a 'tick stop' designed to get hit on a meaningless wick, then force re-entry higher. The real structural stop should be much further away given $1.06T market cap, $365B in cash, and aggressive buyback support
→ vs conservative: The conservative framework misreads cheap trailing P/E of 12.49x as simply 'cheap' when it's actually artificially deflated by $14.85B in investment marks. The operating earnings power (32.56% margin, $72B FCF) justifies a premium, not a discount
→ vs neutral: The 'wait for $503 with MACD histogram contracting' trigger is a $6-7 chase trade that means buying AFTER momentum has already turned. The point of buying dips is buying BEFORE confirmation
→ vs neutral: Balanced evidence in a stock 6% off its high with the long-term trend intact, with a new CIO making first aggressive capital allocation moves, with a fortress balance sheet, and with a purpose-built macro environment does not justify defensive posture
| MACD Signal | 3.47 | neutral |
| MACD Peak | +8.38 (2026-08-10) | bearish |
| MACD Histogram | -2.84 | bearish |
| Bollinger Upper Band | $529.34 | neutral |
| Bollinger Middle Band | $509.75 | neutral |
| Bollinger Lower Band | $490.15 | neutral |
| ATR(14) | 7.66 | neutral |
| ATR Low | 6.38 (2026-07-27) | neutral |
| Peak Close | $529.42 (2026-08-10) | neutral |
| Intraday High Peak | $537.74 (2026-08-10) | bearish |
| Upper Band Peak | $532.94 (2026-08-11) | neutral |
Support: 496.86 · 490.15 · 492.02 | Resistance: 500.15 · 504.96 · 509.75
BRK-B is in a short-term pullback following a $537.74 intraday spike on 2026-08-10, having declined 6.1% to close at $496.86 on 2026-08-20. The 200 SMA (492.02) represents the critical long-term uptrend support, while the 10 EMA (504.96) and 50 SMA (500.15) form immediate resistance overhead. RSI (42.76) has reset from overbought (74.55) but not yet reached oversold territory, and the MACD histogram (-2.84) continues to expand negatively, indicating momentum deterioration with no stabilization signal yet. Volume on the latest session (2,344,741) was the lowest of the pullback, suggesting selling exhaustion but not yet a confirmed bottom. The proposed transaction is HOLD: existing longs may maintain positions with ATR-based stops (~$481.70 for a 2×ATR stop from $497 entry), while fresh entries should await either a test of the $492–$490 support zone with a bullish reversal candle or a daily close above the 10 EMA ($504.96) with RSI reclaiming 50.
Market Cap
$1.0636 trillion
TTM P/E Ratio
12.49x
Forward P/E
22.39x
PEG Ratio
10.06
EPS (TTM)
$39.77
Forward EPS
$22.19
Beta (5Y)
0.607
52-Week Range
$464.01 – $537.74
50-Day Average
$499.97
200-Day Average
$491.93
TTM Revenue
$384.69B
TTM Gross Profit
$116.68B
Gross Margin
30.3%
TTM EBITDA
$130.68B
TTM Net Income
$85.77B
Net Margin
22.30%
Operating Margin
32.56%
Return on Equity (ROE)
12.12%
Return on Assets (ROA)
6.01%
Free Cash Flow (TTM)
$71.98B
Q2 2026 Revenue
$117.89B
Q2 2026 Net Income
$25.67B
Q2 2026 YoY Net Income Growth
+107%
Q2 2026 Diluted EPS
$11.91
Q1 2026 Revenue
$92.07B
Q1 2026 Net Income
$10.11B
Q1 2026 YoY Net Income Growth
+120%
Q1 2026 Diluted EPS
$4.68
Q4 2025 Revenue
$111.44B
Q4 2025 Net Income
$19.20B
Q4 2025 Diluted EPS
$14.28
Q2 2025 Revenue
$98.88B
Q2 2025 Net Income
$12.37B
Q2 2025 Diluted EPS
$5.73
Q1 2025 Revenue
$83.29B
Q1 2025 Net Income
$4.60B
Q1 2025 Diluted EPS
$2.13
Total Assets (Q2 2026)
$1,263.07B
Stockholders' Equity (Q2 2026)
$747.91B
Total Liabilities (Q2 2026)
$512.89B
Cash & ST Investments (Q2 2026)
$365.51B
Long-Term Debt (Q2 2026)
$125.94B
Net Debt (Q2 2026)
$87.99B
Current Ratio (Q2 2026)
2.89x
Debt/Equity (Q2 2026)
17.14%
Total Equity / Total Assets (Q2 2026)
59.2%
Goodwill + Intangibles (Q2 2026)
$117.12B
Net PPE (Q2 2026)
$244.14B
Investments & Advances (Q2 2026)
$685.67B
Equity Investments (Q2 2026)
$323.78B
Q2 2026 Operating Cash Flow
$11.22B
Q2 2026 Free Cash Flow
$5.57B
Q2 2026 Capex
$5.65B
Q2 2026 Net Buybacks
$4.21B
Q2 2026 Net Investment Activity
$18.26B
Q2 2026 Unrealized Losses on Investments
$16.05B
Q2 2026 Other Income/Expense
$14.85B
Strengths
Concerns
Berkshire Hathaway demonstrates exceptional fundamental strength with record Q2 2026 earnings of $25.67B, a fortress balance sheet featuring $365.5B in cash, and conservative 17.1% debt-to-equity leverage. The company initiated meaningful share buybacks ($4.21B in Q2 2026) signaling potential undervaluation, while maintaining strong operating cash flows of ~$10-11B per quarter. However, the wide divergence between TTM P/E (12.49x) and forward P/E (22.39x), combined with $16.05B in unrealized portfolio losses and projected ~44% earnings decline, raises concerns about earnings quality and sustainability. The investment-driven earnings boost in 2026 may not be repeatable, warranting a HOLD recommendation for existing shareholders with careful position sizing advised for new entrants given elevated multiples and market proximity to moving averages.
Macro: Risk-off tape with a rates shock: geopolitical escalation with Iran (Trump threatens severe economic actions; US–Iran deal by 8/31 at 0% on Polymarket), energy spike (WTI $90 odds +24pp WoW to 55%), and long-end yields blowout (30-year Treasury still above 5%; US federal debt crossed $40 trillion). Treasury buyback operations failed to calm the market (WSJ: "U.S. Stocks and Bonds Slide, Brushing Off Treasury's Buyback Plans"). Fed is firmly on hold: Polymarket "no Fed rate cuts in 2026" at 86% ($7.4M volume); all 6+ cut scenarios trade at effectively 0%. Inflation contained: >4.5% in 2026 at 14% (−5pp WoW); >5% at 8%. US recession by end-2026 implied at 8% (low but not spiking); Japan recession at 35% (+7pp WoW) is the marginal concern. Tape signals: Walmart earnings miss + SpaceX/CrowdStrike weakness + bond-yield rise = IBD bearish trigger. The macro setup is unambiguously the kind Buffett designed Berkshire for: high long rates, energy shock, geopolitical risk, and a stalled Fed.